Phenominer Database Results (100 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Experiment Notes Record ID Study ID
Hsd:WI plasma urea nitrogen level phosphate buffered saline (for 25 days) Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. blood urea nitrogen amount male 0 days 8 8.7 mmol/l 0.47 1.34 liquid phase colorimetry 0.0 0 75939 1542
Hsd:WI plasma creatinine level phosphate buffered saline (for 25 days) Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. blood creatinine amount male 0 days 8 0.31 mg/dl 0.02 0.05 liquid phase colorimetry 0.0 0 75943 1542
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 354.0 uV 16.81 41.18 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs b-wave amplitude ERG 108531 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 382.33 uV 22.98 56.29 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs b-wave amplitude ERG 108532 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 419.0 uV 21.83 53.47 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs b-wave amplitude ERG 108533 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 25.3 uV 2.85 6.98 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa a-wave amplitude ERG 108399 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 109.52 uV 22.74 55.7 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa a-wave amplitude ERG 108400 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 460.67 uV 47.48 116.3 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa b-wave amplitude ERG 108411 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 26.68 uV 7.67 18.79 electroretinography cornea 0.0 subretinal injection 30 min pbs a-wave amplitude ERG 108447 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 438.83 uV 24.27 59.45 electroretinography cornea 0.0 subretinal injection 30 min pbs b-wave amplitude ERG 108460 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 584.5 uV 38.15 93.45 electroretinography cornea 0.0 subretinal injection 30 min pbs b-wave amplitude ERG 108462 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 201.55 uV 19.9 66.0 electroretinography cornea 0.0 subretinal injection 2 days pbs a-wave amplitude ERG 108475 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 410.45 uV 48.4 160.52 electroretinography cornea 0.0 subretinal injection 2 days pbs b wave amplitude ERG 108483 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 178.0 uV 12.3 30.13 electroretinography cornea 0.0 subretinal injection 10 days pbs a wave amplitude ERG 108498 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 587.17 uV 49.54 121.35 electroretinography cornea 0.0 subretinal injection 10 days pbs b wave amplitude ERG 108509 3123
BDIX/OrlIco metastatic liver tumor area PRObR1 cells (2 x 10E6 cells) then phosphate buffered saline (1 ml) (for 7 days) Cordel S, etal., Int J Cancer. 1998 Dec 9;78(6):735-9. doi: 10.1002/(sici)1097-0215(19981209)78:6<735::aid-ijc11>3.0.co;2-6. liver integrity trait male 116 days-146 days 6 median 40.5 mm2 magnetic resonance imaging 0.0 0 BDIX/OrlIco 109115 3085
RCS-p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 19.05 uV 3.75 9.92 electroretinography cornea 0.0 subretinal injection 4 days MPEP a-wave amplitude ERG 108550 3123
RCS-p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 31.96 uV 9.73 25.74 electroretinography cornea 0.0 subretinal injection 4 days MPEP a-wave amplitude ERG 108553 3123
RCS-p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 10.28 uV 1.69 4.47 electroretinography cornea 0.0 subretinal injection 4 days pbs b-wave amplitude ERG 108554 3123
RCS-p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 159.83 uV 21.35 56.49 electroretinography cornea 0.0 subretinal injection 4 days pbs b-wave amplitude ERG 108558 3123
RCS-p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 179.49 uV 20.75 54.9 electroretinography cornea 0.0 subretinal injection 4 days pbs b-wave amplitude ERG 108559 3123
Hsd:WI kidney superoxide dismutase to paraoxonase1 activity ratio phosphate buffered saline (for 25 days) Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. kidney superoxide dismutase activity male 0 days 8 13.88 null 0.5 1.41 liquid phase colorimetry 0.0 0 76225 1542
Hsd:WI plasma uric acid level phosphate buffered saline (for 25 days) Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. blood uric acid amount male 0 days 8 2.97 mg/dl 0.18 0.51 liquid phase colorimetry 0.0 0 75947 1542
Hsd:WI kidney superoxide dismutase to catalase activity ratio phosphate buffered saline (for 25 days) Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. kidney superoxide dismutase activity male 0 days 8 1.98 null 0.07 0.21 liquid phase colorimetry 0.0 0 76217 1542
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 16.11 uV 3.41 8.35 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs a-wave amplitude ERG 108519 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 47.53 uV 9.4 23.03 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs b-wave amplitude ERG 108530 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 190.68 uV 32.08 78.58 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa a-wave amplitude ERG 108402 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 224.32 uV 34.64 84.85 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa a-wave amplitude ERG 108403 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 638.33 uV 68.2 167.06 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa b-wave amplitude ERG 108414 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 7.62 uV 1.56 3.82 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa a-wave amplitude ERG 108422 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 27.7 uV 4.72 11.56 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa a-wave amplitude ERG 108423 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 94.57 uV 13.87 33.97 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa a-wave amplitude ERG 108424 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 202.33 uV 17.65 43.23 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa a-wave amplitude ERG 108426 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 42.97 uV 8.99 22.02 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa b-wave amplitude ERG 108434 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 497.33 uV 42.65 104.47 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa b-wave amplitude ERG 108437 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 218.83 uV 22.09 54.11 electroretinography cornea 0.0 subretinal injection 30 min pbs a-wave amplitude ERG 108451 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 358.5 uV 35.71 87.47 electroretinography cornea 0.0 subretinal injection 30 min pbs b-wave amplitude ERG 108459 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 100.23 uV 12.78 31.3 electroretinography cornea 0.0 subretinal injection 10 days pbs a wave amplitude ERG 108496 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 393.0 uV 65.49 160.42 electroretinography cornea 0.0 subretinal injection 10 days pbs b wave amplitude ERG 108507 3123
BDIX/OrlIco metastatic liver tumor area PRObR1 cells (2 x 10E6 cells) then phosphate buffered saline (1 ml) (for 7 days) Cordel S, etal., Int J Cancer. 1998 Dec 9;78(6):735-9. doi: 10.1002/(sici)1097-0215(19981209)78:6<735::aid-ijc11>3.0.co;2-6. liver integrity trait male 151 days-181 days 6 median 179.0 mm2 magnetic resonance imaging 0.0 0 BDIX/OrlIco 109116 3085
RCS-p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 15.31 uV 2.98 7.88 electroretinography cornea 0.0 subretinal injection 4 days MPEP a-wave amplitude ERG 108549 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 570.67 uV 53.5 131.05 electroretinography cornea 0.0 subretinal injection 10 days pbs b wave amplitude ERG 108510 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 89.88 uV 11.06 27.09 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs a-wave amplitude ERG 108521 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 423.33 uV 25.5 62.46 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs b-wave amplitude ERG 108534 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 9.73 uV 2.39 5.85 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa a-wave amplitude ERG 108398 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 532.5 uV 62.77 153.75 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa b-wave amplitude ERG 108412 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 592.83 uV 68.9 168.77 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa b-wave amplitude ERG 108413 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 652.5 uV 65.65 160.81 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa b-wave amplitude ERG 108415 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 570.67 uV 21.08 51.64 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa b-wave amplitude ERG 108438 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 516.5 uV 29.8 72.99 electroretinography cornea 0.0 subretinal injection 30 min pbs b-wave amplitude ERG 108461 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 18.46 uV 3.3 10.94 electroretinography cornea 0.0 subretinal injection 2 days pbs a-wave amplitude ERG 108471 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 144.39 uV 13.24 43.91 electroretinography cornea 0.0 subretinal injection 2 days pbs a-wave amplitude ERG 108473 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 518.55 uV 54.69 181.39 electroretinography cornea 0.0 subretinal injection 2 days pbs b wave amplitude ERG 108485 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 607.73 uV 58.9 195.35 electroretinography cornea 0.0 subretinal injection 2 days pbs b wave amplitude ERG 108487 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 13.98 uV 3.06 7.5 electroretinography cornea 0.0 subretinal injection 10 days pbs a wave amplitude ERG 108494 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 101.1 uV 20.75 50.83 electroretinography cornea 0.0 subretinal injection 10 days pbs b wave amplitude ERG 108506 3123
BDIX/OrlIco post-insult time of death due to metastatic liver tumors PRObR1 cells (2 x 10E6 cells) then phosphate buffered saline (1 ml) (for 7 days) Cordel S, etal., Int J Cancer. 1998 Dec 9;78(6):735-9. doi: 10.1002/(sici)1097-0215(19981209)78:6<735::aid-ijc11>3.0.co;2-6. life span trait male 174 days-230 days 6 median 114.0 d necropsy 0.0 0 post-insult time of death due to metastatic liver tumors (CMO:0003882) survival 107418 3085
RCS-p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 24.79 uV 7.82 20.69 electroretinography cornea 0.0 subretinal injection 4 days MPEP a-wave amplitude ERG 108552 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 455.17 uV 35.54 87.05 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs b-wave amplitude ERG 108535 3123
Hsd:WI kidney superoxide dismutase activity to total protein level ratio phosphate buffered saline (for 25 days) Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. kidney superoxide dismutase activity male 0 days 8 239.5 U/mg 7.28 20.6 liquid phase colorimetry 0.0 0 76199 1542
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 57.63 uV 8.8 21.56 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs a-wave amplitude ERG 108520 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 124.83 uV 7.26 17.78 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs a-wave amplitude ERG 108522 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 138.93 uV 9.28 22.73 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs a-wave amplitude ERG 108523 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 62.22 uV 18.42 45.12 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa b-wave amplitude ERG 108410 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 8.38 uV 1.81 4.43 electroretinography cornea 0.0 subretinal injection 30 min pbs a-wave amplitude ERG 108446 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 49.97 uV 12.07 29.57 electroretinography cornea 0.0 subretinal injection 30 min pbs b-wave amplitude ERG 108458 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 598.67 uV 39.64 97.1 electroretinography cornea 0.0 subretinal injection 30 min pbs b-wave amplitude ERG 108463 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 12.43 uV 2.29 7.6 electroretinography cornea 0.0 subretinal injection 2 days pbs a-wave amplitude ERG 108470 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 170.91 uV 16.52 54.79 electroretinography cornea 0.0 subretinal injection 2 days pbs a-wave amplitude ERG 108474 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 56.72 uV 16.42 54.46 electroretinography cornea 0.0 subretinal injection 2 days pbs b wave amplitude ERG 108482 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 30.66 uV 9.93 24.32 electroretinography cornea 0.0 subretinal injection 10 days pbs a wave amplitude ERG 108495 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 206.0 uV 11.62 28.46 electroretinography cornea 0.0 subretinal injection 10 days pbs a wave amplitude ERG 108499 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 533.17 uV 67.99 166.54 electroretinography cornea 0.0 subretinal injection 10 days pbs b wave amplitude ERG 108508 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 161.92 uV 30.48 74.66 electroretinography cornea 0.0 subretinal injection 7 days dl-aaa a-wave amplitude ERG 108401 3123
RCS-p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 32.75 uV 13.42 35.51 electroretinography cornea 0.0 subretinal injection 4 days pbs b-wave amplitude ERG 108555 3123
RCS-p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 94.13 uV 15.33 40.56 electroretinography cornea 0.0 subretinal injection 4 days pbs b-wave amplitude ERG 108556 3123
Hsd:WI kidney glutathione peroxidase activity to glutathione reductase activity ratio phosphate buffered saline (for 25 days) Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. kidney glutathione peroxidase activity male 0 days 8 59.12 null 1.93 5.47 liquid phase colorimetry 0.0 0 76213 1542
Hsd:WI kidney paraoxonase1 activity to total protein level ratio phosphate buffered saline (for 25 days) Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. kidney paraoxonase 1 activity male 0 days 8 17.25 U/mg 0.61 1.73 liquid phase colorimetry 0.0 0 76209 1542
Hsd:WI kidney superoxide dismutase to glutathione peroxidase ratio phosphate buffered saline (for 25 days) Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. kidney superoxide dismutase activity male 0 days 8 8.66 null 0.41 1.15 liquid phase colorimetry 0.0 0 76221 1542
Hsd:WI kidney glutathione level phosphate buffered saline (for 25 days) Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. kidney glutathione amount male 0 days 8 123.7 ug/g 1.78 5.04 liquid phase colorimetry 0.0 0 76229 1542
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 625.0 uV 55.4 135.7 electroretinography cornea 0.0 subretinal injection 10 days pbs b wave amplitude ERG 108511 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform DL-α-aminoadipate (70 ug/ul) and phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 16.61 uV 4.28 10.48 electroretinography cornea 0.0 subretinal injection 2 days dl-aaa + pbs a-wave amplitude ERG 108518 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 149.83 uV 9.83 24.08 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa a-wave amplitude ERG 108425 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 243.17 uV 24.11 59.06 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa a-wave amplitude ERG 108427 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-2.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 356.17 uV 23.35 57.2 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa b-wave amplitude ERG 108435 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 399.83 uV 37.74 92.44 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa b-wave amplitude ERG 108436 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (1 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 621.67 uV 35.23 86.3 electroretinography cornea 0.0 subretinal injection 10 days dl-aaa b-wave amplitude ERG 108439 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 78.77 uV 13.41 32.85 electroretinography cornea 0.0 subretinal injection 30 min pbs a-wave amplitude ERG 108448 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 146.78 uV 16.49 40.39 electroretinography cornea 0.0 subretinal injection 30 min pbs a-wave amplitude ERG 108449 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 190.83 uV 21.76 53.3 electroretinography cornea 0.0 subretinal injection 30 min pbs a-wave amplitude ERG 108450 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 87.05 uV 8.87 29.42 electroretinography cornea 0.0 subretinal injection 2 days pbs a-wave amplitude ERG 108472 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 466.45 uV 51.69 171.44 electroretinography cornea 0.0 subretinal injection 2 days pbs b wave amplitude ERG 108484 3123
RCS-rdy+ p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (0.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 11 567.73 uV 56.78 188.32 electroretinography cornea 0.0 subretinal injection 2 days pbs b wave amplitude ERG 108486 3123
RCS-rdy+ p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 0 days 6 145.83 uV 14.32 35.08 electroretinography cornea 0.0 subretinal injection 10 days pbs a wave amplitude ERG 108497 3123
BDIX/OrlIco post-insult time of death due to metastatic liver tumors PROb cells (2 x 10E6 cells) then phosphate buffered saline (1 ml) (for 7 days) Cordel S, etal., Int J Cancer. 1998 Dec 9;78(6):735-9. doi: 10.1002/(sici)1097-0215(19981209)78:6<735::aid-ijc11>3.0.co;2-6. life span trait male 94 days-130 days 6 median 34.0 d necropsy 0.0 0 post-insult time of death due to metastatic liver tumors (CMO:0003882) survival 107419 3085
RCS-p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-4.5 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 3.13 uV 1.81 4.79 electroretinography cornea 0.0 subretinal injection 4 days MPEP a-wave amplitude ERG 108548 3123
RCS-p+/LavRrrc scotopic A wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 31.22 uV 8.16 21.59 electroretinography cornea 0.0 subretinal injection 4 days MPEP a-wave amplitude ERG 108551 3123
RCS-p+/LavRrrc scotopic B wave amplitude of ERG waveform phosphate buffered saline (4 ul) then controlled exposure to darkness (for 12 hours) then visible light stimulus (-0.02 log(cd x m/s2)) Dai J, et al., Sci Rep. 2017 Jun 14;7(1):3546. doi: 10.1038/s41598-017-03702-z. rod electrophysiology trait both 39 days 7 131.7 uV 16.13 42.68 electroretinography cornea 0.0 subretinal injection 4 days pbs b-wave amplitude ERG 108557 3123
BDIX/OrlCrl percentage of study population developing peritoneal carcinomatosis during a period of time phosphate buffered saline (0.2 ml) then phosphate buffered saline (0.1 ml) Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x. peritoneum integrity trait male 0 days 3 0.0 % 0.0 0.0 necropsy 0.0 30 days sham surgical group 111027 3195
BDIX/OrlCrl number of small metastatic liver tumors phosphate buffered saline (0.2 ml) then phosphate buffered saline (0.1 ml) Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x. liver integrity trait male 0 days 3 0.0 null 0.0 0.0 ex vivo light microscopy with histochemistry 0.0 30 days sham surgical group 111057 3195